Watch Ticker

Silence Therapeutics Plc American Depository Share

Go to Silence Therapeutics Plc American Depository Share Website

$5.32

-0.29 (-5.17%)

Live

Previous Close

$5.61

Day Range

$5.27 - $5.64

Previous Day Range

$5.43 - $5.95

Market Cap

$265.0 million USD

Day Vol.

49725

Previous Day Vol.

75358

Currency

USD

Primary Exchange

Nasdaq

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment

BESREMi, a FDA-approved treatment for polycythemia vera, is gaining market share due to its potential for better tolerability and lower risk of treatment-related malignancies compared to competitors like ruxolitinib and hydroxyurea.

Related tickers: NVS, PTGX, IONS, MRK, SLN, ABBV, BMY, CELGr, GSKH.

Read Full Article

Towards Healthcare - RNA Based Therapeutic Market Size Expected to Reach USD 40.81 Bn by 2034

The global RNA-based therapeutic market is expected to grow from $9.46 billion in 2025 to $40.81 billion by 2034, driven by the rising prevalence of genetic disorders and the demand for personalized medicine. North America and Asia Pacific are the key regional markets.

Related tickers: IONS, ALNY, BNTC, SLN, XLO.

Read Full Article

Trending Tickers

Please sign in to view